NeuroSense Therapeutics Ltd. (NRSN) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

NeuroSense Therapeutics Ltd.

NRSN

NASDAQ

Unprofitable

Unprofitable

26M

Biotechnology

1.12USD

0.07 ( 6.67%)

Relative Strenght

42

Volume Buzz

-37%

Earning Acce

No

Dist 52w H.

52%

Quote Panel

Updated January 17, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

Relative Strength

NRSN

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.22

N/A

-0.25
vs -0.08

Q4.22

N/A

-0.27
vs -0.24

Q1.23

N/A

-0.33
vs -0.24

Q2.23

N/A

-0.44
vs -0.31

Q3.23

+140%

0.1
vs -0.25

Q4.23

N/A

-0.16
vs -0.27

Q1.24

N/A

-0.16
vs -0.33

Q2.24

N/A

-0.02
vs -0.44

Q3.24

N/A

-0.11
vs 0.1

Q4.24

N/A

-0.08
vs -0.16

Sales Growth

YoY

Current

Estimates

Q2.22

NA

NA vs NA

Q3.22

NA

NA vs NA

Q4.22

NA

NA vs NA

Q1.23

NA

NA vs NA

Q2.23

NA

NA vs NA

Q3.23

NA

NA vs NA

Q4.23

NA

NA vs NA

Q1.24

NA

NA vs NA

Q2.24

NA

NA vs NA

Q3.24

NA

NA vs NA

Return on Equity

QoQ

Q4.22

-53%

-0.53
vs -0.34

Q1.23

-132%

-1.32
vs -0.53

Q2.23

+338%

3.38
vs -1.32

Q3.23

-400%

-4.00
vs 3.38

Q4.23

+157%

1.57
vs -4.00

Q1.24

+77%

0.77
vs 1.57

Q2.24

+50%

0.5
vs 0.77

Q3.24

+76%

0.76
vs 0.5

Institutionnal Ownership

QoQ

Q4.22

5

5
vs 4

25%

Q1.23

5

5
vs 5

NA

Q2.23

6

6
vs 5

20%

Q3.23

5

5
vs 6

-17%

Q4.23

8

8
vs 5

60%

Q1.24

8

8
vs 8

NA

Q2.24

7

7
vs 8

-12%

Q3.24

7

7
vs 7

NA

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!

Shape

Shape